Viewing Study NCT03391960



Ignite Creation Date: 2024-05-06 @ 10:57 AM
Last Modification Date: 2024-10-26 @ 12:37 PM
Study NCT ID: NCT03391960
Status: COMPLETED
Last Update Posted: 2022-02-09
First Post: 2017-12-07

Brief Title: Passive Disinfection Cap Compliance Study
Sponsor: 3M
Organization: 3M

Study Overview

Official Title: A Compliance Improvement Project to Reduce Central Line Associated Blood Stream Infection CLABSI Using a Passive Disinfection Device in an Adult Oncological Hospital in Brazil
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Insertion and maintenance of central venous catheter CVC lines are common hospital procedures in patients including those being treated for cancer CVCs allow clinicians an access point for infusion of fluids blood sampling and measurements decreasing the need for repeated needle sticks to the patient However bloodstream infections associated with CVCs CLABSIs are a serious complication leading to significantly longer hospital stays morbidity and mortality Keeping catheter ports disinfected reduces the risk of bloodstream infection however consistent and adequate maintenance and disinfection of the line can be difficult

The purpose of this study is to demonstrate that passive disinfecting caps can provide a patient safety practice that is easy for clinicians to follow as well as providing easily auditable compliance which may lead to lower CLABSI rates

The compliance rate for needleless connector disinfection will be evaluated after implementation of the passive disinfecting cap and compared to the pre-intervention rate The CLABSI rates before and after cap implementation will also be compared
Detailed Description: Insertion and maintenance of central venous catheter CVC lines are common hospital procedures in patients including those being treated for cancer CVCs allow clinicians an access point for infusion of fluids blood sampling and measurements decreasing the need for repeated needle sticks to the patient However bloodstream infections associated with CVCs CLABSIs are a serious complication leading to significantly longer hospital stays morbidity and mortality Keeping catheter ports disinfected reduces the risk of bloodstream infection however consistent and adequate maintenance and disinfection of the line can be difficult

The purpose of this study is to demonstrate that passive disinfecting caps can provide a patient safety practice that is easy for clinicians to follow as well as providing easily auditable compliance which may lead to lower CLABSI rates

Compliance is defined as following the protocol for disinfection of the catheter port In the pre-intervention period the disinfection protocol will utilize existing institution scrub-the-hub method Compliance in the pre-intervention period will be determined by survey

After the pre-intervention period is complete passive disinfecting devices caps will be implemented hospital-wide for any adult patient using CVC ports

In the intervention period the disinfection protocol consists of using the disinfecting barrier cap on every needless connector catheter port used for accessing CVC IV lines per protocol Compliance will be measured using observations according to a schedule to ensure the absence of a shift bias Observations will contain the number of needless connectors on CVCs with and the number of needleless connectors without disinfecting barrier caps attached

The compliance rate for needleless connector disinfection will be evaluated after implementation of the passive disinfecting cap and compared to the pre-intervention rate The CLABSI rates before and after cap implementation will also be compared

Incidence of CLABSI will be noted from existing aggregate hospital surveillance system data The incidence in terms of catheter days will be recorded for each assigned intervention ward and for intervention ward overall by month in the six months before the intervention and in the six-month intervention recording period

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
Study 05-014137 OTHER 3M None